{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:17:36Z","timestamp":1793578656356,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Education, Culture, Sports, Science, and Technology; the broad-area, network-based Project to Drive Clinical Research at Kyushu University Hospital"},{"name":"Diffuse Lung Diseases Research Group from the Ministry of Health, Labour and Welfare, Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Low skeletal muscle mass has been reported to associated with poor prognosis in patients with idiopathic pulmonary fibrosis (IPF). However, such associations have scarcely reported in idiopathic interstitial pneumonias (IIPs) other than IPF. Quantification of muscle mass obtained from chest computed tomography (CT) is used as a simple screening tool for sarcopenia in patients with respiratory diseases. However, the optimal thoracic site for muscle mass quantification is controversial. Moreover, there have been no reports investigating the association between muscle mass and acute exacerbations. This study aimed to evaluate optimal site for muscle mass quantification in chest CT to predict survival and acute exacerbation in IPF and non-IPF idiopathic interstitial pneumonias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included 528 patients diagnosed with IIP at 29 facilities between September 1, 2013, and April 30, 2016, following multidisciplinary discussions with prospective follow-up over a 5-year period. The cohort was divided into two groups: those with IPF and those with non-IPF IIPs. Skeletal muscle mass was quantified using the erector spinae muscle index (ESMI) and pectoralis muscle index (PMI), defined as the respective muscle area on chest computed tomography (CT) divided by height squared at the time of enrollment. Associations between these indices at baseline and both survival and acute exacerbation were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In both IPF and non-IPF cohorts, Cox regression analysis revealed that patients with low ESMI had a poorer prognosis compared to those with normal ESMI, even after adjusting for age, sex, % forced vital capacity (FVC), and smoking exposure level. The hazard ratios were 0.62 (95% CI 0.40\u20130.90;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.013) and 0.46 (95% CI 0.26\u20130.83;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009), respectively. In contrast, no significant relationship was identified between PMI and survival. Multivariable Cox regression analysis confirmed that ESMI was an independent predictor of survival in both IPF and non-IPF patients. Additionally, acute exacerbations occurred more frequently in the low ESMI group and low PMI group, particularly among non-IPF patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The ESMI obtained from chest CT is associated with survival in not only in IPF patients but also in the non-IPF patients. The ESMI and PMI also associate with acute exacerbations in non-IPF patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-025-03942-0","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T13:09:06Z","timestamp":1760447346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic impact of muscle mass in idiopathic interstitial pneumonia: analysis of idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias"],"prefix":"10.1186","volume":"25","author":[{"given":"Hirotaka","family":"Hagiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomotsugu","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Tsubouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Ichiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Kitasato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Zaizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Yatera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashige","family":"Maeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Mashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Furuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Torii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Tobino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Kiyomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetake","family":"Yabuuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"3942_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1183\/09031936.00185114","volume":"46","author":"J Hutchinson","year":"2015","unstructured":"Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J. 2015;46:795\u2013806.","journal-title":"Eur Respir J"},{"key":"3942_CR2","doi-asserted-by":"publisher","first-page":"e001864","DOI":"10.1136\/bmjresp-2023-001864","volume":"10","author":"K Tsubouchi","year":"2023","unstructured":"Tsubouchi K, Hamada N, Tokunaga S, Ichiki K, Takata S, Ishii H, et al. Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry. BMJ Open Resp Res. 2023;10:e001864.","journal-title":"BMJ Open Resp Res"},{"key":"3942_CR3","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1080\/03007995.2019.1647040","volume":"35","author":"M Wijsenbeek","year":"2019","unstructured":"Wijsenbeek M, Kreuter M, Olson A, Fischer A, Bendstrup E, Wells CD, et al. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management. Curr Med Res Opin. 2019;35:2015\u201324.","journal-title":"Curr Med Res Opin"},{"key":"3942_CR4","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s12325-020-01578-6","volume":"38","author":"A Olson","year":"2021","unstructured":"Olson A, Hartmann N, Patnaik P, Wallace L, Schlenker-Herceg R, Nasser M, et al. Estimation of the prevalence of progressive fibrosing interstitial lung diseases: systematic literature review and data from a physician survey. Adv Ther. 2021;38:854\u201367.","journal-title":"Adv Ther"},{"key":"3942_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1164\/rccm.200210-1245OC","volume":"168","author":"PI Latsi","year":"2003","unstructured":"Latsi PI, Du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D, Nikolakopoulou A, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med. 2003;168:531\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"3942_CR6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMra2005230","volume":"383","author":"M Wijsenbeek","year":"2020","unstructured":"Wijsenbeek M, Cottin V. Spectrum of fibrotic lung diseases. N Engl J Med. 2020;383:958\u201368.","journal-title":"N Engl J Med"},{"key":"3942_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"L-K Chen","year":"2020","unstructured":"Chen L-K, Woo J, Assantachai P, Auyeung T-W, Chou M-Y, Iijima K, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300\u2013e3072.","journal-title":"J Am Med Dir Assoc"},{"key":"3942_CR8","doi-asserted-by":"publisher","first-page":"1187760","DOI":"10.3389\/fmed.2023.1187760","volume":"10","author":"J Li","year":"2023","unstructured":"Li J, Lu Y, Deng M, Tong R, Zhang Q, Bian Y, et al. Prevalence and risk factors of sarcopenia in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Front Med. 2023;10:1187760.","journal-title":"Front Med"},{"key":"3942_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/1479972316679664","volume":"14","author":"AE Bone","year":"2017","unstructured":"Bone AE, Hepgul N, Kon S, Maddocks M. Sarcopenia and frailty in chronic respiratory disease. Chron Respir Dis. 2017;14:85\u201399.","journal-title":"Chron Respir Dis"},{"key":"3942_CR10","first-page":"e2021031","volume":"38","author":"EK Symvoulakis","year":"2021","unstructured":"Symvoulakis EK, Kamekis A, Drakonaki E, Mastrodemou S, Ryerson CJ, Antoniou K. Frailty and chronic respiratory disease: the need for a multidisciplinary care model. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38:e2021031.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"3942_CR11","doi-asserted-by":"publisher","first-page":"14074","DOI":"10.1038\/s41598-018-32478-z","volume":"8","author":"Y Suzuki","year":"2018","unstructured":"Suzuki Y, Yoshimura K, Enomoto Y, Yasui H, Hozumi H, Karayama M, et al. Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis. Sci Rep. 2018;8:14074.","journal-title":"Sci Rep"},{"key":"3942_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.rmed.2018.10.023","volume":"145","author":"T Asakura","year":"2018","unstructured":"Asakura T, Yamada Y, Suzuki S, Namkoong H, Okamori S, Kusumoto T, et al. Quantitative assessment of erector spinae muscles in patients with Mycobacterium avium complex lung disease. Respir Med. 2018;145:66\u201372.","journal-title":"Respir Med"},{"key":"3942_CR13","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539\u201347.","journal-title":"J Clin Oncol"},{"key":"3942_CR14","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.clnu.2016.03.010","volume":"35","author":"B Sj\u00f8blom","year":"2016","unstructured":"Sj\u00f8blom B, Gr\u00f8nberg BH, Wentzel-Larsen T, Baracos VE, Hjermstad MJ, Aass N, et al. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer. Clin Nutr. 2016;35:1386\u201393.","journal-title":"Clin Nutr"},{"key":"3942_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1513\/AnnalsATS.201507-446OC","volume":"13","author":"K Tanimura","year":"2016","unstructured":"Tanimura K, Sato S, Fuseya Y, Hasegawa K, Uemasu K, Sato A, et al. Quantitative assessment of erector spinae muscles in patients with chronic obstructive pulmonary Disease. Novel chest computed Tomography-derived index for prognosis. Ann Am Thorac Soc. 2016;13:334\u201341.","journal-title":"Ann Am Thorac Soc"},{"key":"3942_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12931-019-1001-6","volume":"20","author":"SW Moon","year":"2019","unstructured":"Moon SW, Choi JS, Lee SH, Jung KS, Jung JY, Kang YA, et al. Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients. Respir Res. 2019;20:35.","journal-title":"Respir Res"},{"key":"3942_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12931-024-02705-5","volume":"25","author":"M Sridhar","year":"2024","unstructured":"Sridhar M, Bodduluri S, O\u2019Hare L, Blumhoff S, Acosta Lara MDP, De Andrade JA, et al. Association of musculoskeletal involvement with lung function and mortality in patients with idiopathic pulmonary fibrosis. Respir Res. 2024;25:81.","journal-title":"Respir Res"},{"key":"3942_CR18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.crad.2023.08.011","volume":"78","author":"A \u00c7inkoo\u011flu","year":"2023","unstructured":"\u00c7inkoo\u011flu A, Bayraktaro\u011flu S, Ufuk F, Unat \u00d6S, K\u00f6se T, Sava\u015f R, et al. Reduced CT-derived erector spinae muscle area: a poor prognostic factor for short- and long-term outcomes in idiopathic pulmonary fibrosis patients. Clin Radiol. 2023;78:904\u201311.","journal-title":"Clin Radiol"},{"key":"3942_CR19","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1038\/s41598-020-59100-5","volume":"10","author":"A Nakano","year":"2020","unstructured":"Nakano A, Ohkubo H, Taniguchi H, Kondoh Y, Matsuda T, Yagi M, et al. Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis. Sci Rep. 2020;10:2312.","journal-title":"Sci Rep"},{"key":"3942_CR20","doi-asserted-by":"publisher","first-page":"100965","DOI":"10.1016\/j.resmer.2022.100965","volume":"82","author":"T Fujikawa","year":"2022","unstructured":"Fujikawa T, Kondo S, Saito T, Inoue T, Otake K, Misu S, et al. Impact of sarcopenia defined by carina-level skeletal muscle mass on the long-term prognosis of patients with idiopathic pulmonary fibrosis. Respiratory Med Res. 2022;82:100965.","journal-title":"Respiratory Med Res"},{"key":"3942_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official American thoracic society\/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"key":"3942_CR22","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"key":"3942_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.resinv.2019.10.002","volume":"58","author":"S Ogata-Suetsugu","year":"2020","unstructured":"Ogata-Suetsugu S, Hamada N, Tsuda T, Takata S, Kitasato Y, Inoue N, et al. Characteristics of tobacco-related lung diseases in Fukuoka Prefecture, japan: A prospective, multi-institutional, observational study. Respiratory Invest. 2020;58:74\u201380.","journal-title":"Respiratory Invest"},{"key":"3942_CR24","first-page":"S1","volume":"39","author":"Special Committee of Pulmonary Physiology, The Japanese Respiratory Society","year":"2001","unstructured":"Special Committee of Pulmonary Physiology, The Japanese Respiratory Society. Standard values of spirogram and arterial blood gas in normal Japanese subjects. J Jpn Respir Soc. 2001;39:S1\u201317.","journal-title":"J Jpn Respir Soc"},{"key":"3942_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","volume":"147","author":"RN Baumgartner","year":"1998","unstructured":"Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in new Mexico. Am J Epidemiol. 1998;147:755\u201363.","journal-title":"Am J Epidemiol"},{"key":"3942_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00223-013-9757-z","volume":"93","author":"C Cooper","year":"2013","unstructured":"Cooper C, Fielding R, Visser M, van Loon LJ, Rolland Y, Orwoll E, et al. Tools in the assessment of sarcopenia. Calcif Tissue Int. 2013;93:201\u201310.","journal-title":"Calcif Tissue Int"},{"key":"3942_CR27","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1093\/gerona\/glz034","volume":"74","author":"B Amini","year":"2019","unstructured":"Amini B, Boyle SP, Boutin RD, Lenchik L. Approaches to assessment of muscle mass and myosteatosis on computed tomography: A systematic review. J Gerontol Biol Sci Med Sci. 2019;74:1671\u20138.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"3942_CR28","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.crad.2009.04.005","volume":"64","author":"JK Oh","year":"2009","unstructured":"Oh JK, Ahn MI, Kim HL, Park SH, Shin E. Retrodiaphragmatic portion of the lung: how deep is the posterior Costophrenic sulcus on posteroanterior chest radiography? Clin Radiol. 2009;64:786\u201391.","journal-title":"Clin Radiol"},{"key":"3942_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.resinv.2019.11.002","volume":"58","author":"N Awano","year":"2020","unstructured":"Awano N, Inomata M, Kuse N, Tone M, Yoshimura H, Jo T, et al. Quantitative computed tomography measures of skeletal muscle mass in patients with idiopathic pulmonary fibrosis according to a multidisciplinary discussion diagnosis: A retrospective nationwide study in Japan. Respiratory Invest. 2020;58:91\u2013101.","journal-title":"Respiratory Invest"},{"key":"3942_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/MCP.0000000000000509","volume":"24","author":"SA Guler","year":"2018","unstructured":"Guler SA, Ryerson CJ. Unclassifiable interstitial lung disease: from phenotyping to possible treatments. Curr Opin Pulm Med. 2018;24:461\u20138.","journal-title":"Curr Opin Pulm Med"},{"key":"3942_CR31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1183\/09031936.00131912","volume":"42","author":"CJ Ryerson","year":"2013","unstructured":"Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J. 2013;42:750\u20137.","journal-title":"Eur Respir J"},{"key":"3942_CR32","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1513\/AnnalsATS.201801-067OC","volume":"15","author":"SA Guler","year":"2018","unstructured":"Guler SA, Ellison K, Algamdi M, Collard HR, Ryerson CJ. Heterogeneity in unclassifiable interstitial lung Disease. A systematic review and Meta-Analysis. Ann Am Thorac Soc. 2018;15:854\u201363.","journal-title":"Ann Am Thorac Soc"},{"key":"3942_CR33","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.rmed.2004.09.005","volume":"99","author":"O Nishiyama","year":"2005","unstructured":"Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Ogawa T, Watanabe F, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Respir Med. 2005;99:408\u201314.","journal-title":"Respir Med"},{"key":"3942_CR34","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.apmr.2014.01.016","volume":"95","author":"R Kozu","year":"2014","unstructured":"Kozu R, Jenkins S, Senjyu H. Evaluation of activity limitation in patients with idiopathic pulmonary fibrosis grouped according to medical research Council dyspnea grade. Arch Phys Med Rehabil. 2014;95:950\u20135.","journal-title":"Arch Phys Med Rehabil"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03942-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03942-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03942-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:17:20Z","timestamp":1781612240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-025-03942-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3942"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03942-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6717976\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This prospective, multicenter, observational study was approved by the Institutional Review Board of Kyushu University (#25\u2013135, August 23, 2013; #555-00, August 27, 2013) and by the institutional review boards of all participating hospitals. Written informed consent was obtained from all patients. Patients or the public were not involved in the design, or conduct, or reporting, or dissemination plans of our research. Clinical trial number: not applicable. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable since there are no details on individuals reported within the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KTsubouchi has received personal fees from Boehringer Ingelheim Japan Inc. ST has received personal fees from AstraZeneca KK, Boehringer Ingelheim Japan Inc, and Novartis Pharma KK. KY has received personal fees from Boehringer Ingelheim Japan Inc and GlaxoSmithKline K.K. YN has received personal fees from Gaia Biomedicine and Delta-Fly Pharma. IO has received personal fees from Daiichi Sankyo, Chugai Pharma, Lilly, Taiho Pharmaceutical, Ono Pharmaceutical, Bristol-Myers Squibb, MSD Oncology, AstraZeneca KK, Boehringer Ingelheim Japan Inc, Takeda Pharmaceutical Company Limited, and Novartis Pharma K.K.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"468"}}